The National Institute for Health Research (NIHR) has issued a call for research into the evaluation of public health measures, health care interventions and health services to reduce the development and spread of antimicrobial resistance and consequent morbidity. Participating programmes have varying opening and closing dates with the EME, HS&DR and HTA Programmes opening first.
This call for research is part of a coordinated response by the NIHR to the publication of the 2nd volume of the2011 Annual Report of the Chief Medical Officer: Infections and the rise of antimicrobial resistance. It will also support the Department of Health-led UK Antimicrobial Resistance Strategy which sets out how the challenges outlined in the report will be met.
This call is intended to cover all aspects of translational, clinical and public health research that could through new developments or changes in practice, contribute to a reduction in the development and spread in humans of organisms with antimicrobial resistance, and infection. Research may encompass better prevention, improved surveillance and monitoring and diagnosis as well as the more effective use of existing antibiotics, improved education and training and the development of new antimicrobial therapies and better treatment strategies.
The following eight NIHR managed research programmes are participating:
- Efficacy and Mechanism Evaluation (EME)
- Health Services & Delivery Research (HS&DR)
- Health Technology Assessment (HTA)
- Invention for Innovation (i4i)
- Programme Grants for Applied Research (PGfAR)
- Public Health Research (PHR)
- Research for Patient Benefit (RfPB)
- NIHR Fellowships programmes
Research proposals must be within the remit of one of the participating programmes and applicants should carefully consider the remit described for each programme. However, this call provides opportunities to evaluate interventions which cross NIHR programme boundaries and applications which span the remit of one or more NIHR programme will be considered. The inclusion of patient views and experiences are considered important by each participating programme.
For further information including useful resources and how you can apply, please visit:www.themedcalls.nihr.ac.uk/amr